# Phase 16 Benchmark Implementation Audit

Date: 2026-08-06  
Implementation: `c08fc98`

## Result

**PASS for the deterministic local Phase 16 boundary.** The implementation
does not make a subjective quality decision or a production-label decision.

## Verified controls

| Control | Result | Evidence |
|---|---|---|
| Canonical report identity binds project, pack, snapshot and executable plan | PASS | `engine/benchmark.py::compile_benchmark` |
| Candidate-to-prior comparison is domain/snapshot bound and numeric only | PASS | `compare_benchmarks` and focused test |
| Business-tech reference profile is strict and brand/source-media free | PASS | `domain-packs/business-tech/benchmarks/composition_profile_v1.json` |
| Cross-domain and forged-profile comparison fails closed | PASS | `tests/test_phase16_benchmark.py` |
| No third-party media read/download, UI label, provider, queue or renderer was added | PASS | implementation diff and authorization scope |

## Roadmap-metric status

Derived from canonical plans/EDLs: sequence count, duration, base-shot density,
edit-event density, template/asset-brief distributions, static-duration proxy,
audio event/track/boundary distributions.

`chapter_structure`, source density/treatment, stock/chart/quote ratios,
kinetic-text density and actual source-audio use are canonical `UNAVAILABLE`.
They have no positive delta or in-range success path. Their evidence owner is
the Phase 17 operational source/asset/timing product gate; the three external
reference videos are likewise Phase 17 evidence under
`baseline/phase16_scope_reconciliation.md`.

## Test evidence

- `python -m py_compile engine/benchmark.py` — PASS
- `python -m pytest tests/test_phase16_benchmark.py -q` — `2 passed`
- `python -m pytest tests/test_phase12_editorial_integration.py -q` — `6 passed`
- Combined Phase 3/12/audio regression command exceeded the 120-second command
  limit; no pass is claimed for that broad run.

## Conclusion

The deterministic Phase 16 local benchmark foundation is accepted. It is not
external-reference ingestion, quality certification, or Phase 17 production
evidence.
